Evidence-Based Oncology


Readership

Evidence-Based Oncology circulates to nearly 20,500 individuals with important decision-making responsibilities that influence the access and utilization of healthcare resources. Our audience includes medical directors, Medicaid directors, pharmacy and therapeutics committee members, pharmacy directors, formulary directors, physicians, corporate benefits managers, and other healthcare professionals across these 6 market segments: (1) HMO/PPO/IHOs; (2) hospitals; (3) long-term care; (4) PBMs; (5) VA/government; and (6) employers.